Citation Tools

Download PDFPDF
Original research
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies

Download to a citation manager

Cite this article as:
Doneddu PE, Cocito D, Fazio R, et al
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies